Application 202961
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | SUSPENSION;ORAL | 300MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50268-649 | Oxcarbazepine | Oxcarbazepine | AvPAK | ANDA | Current |
| 50268-649 | Oxcarbazepine | Oxcarbazepine | AvPAK | ANDA | Current |
| 50268-649 | Oxcarbazepine | Oxcarbazepine | AvPAK | ANDA | Current |
| 65162-649 | Oxcarbazepine | Oxcarbazepine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-649 | Oxcarbazepine | Oxcarbazepine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-649 | Oxcarbazepine | Oxcarbazepine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 68094-123 | Oxcarbazepine | Oxcarbazepine | Precision Dose, Inc. | ANDA | Current |
| 70518-2946 | Oxcarbazepine | Oxcarbazepine | REMEDYREPACK INC. | ANDA | Current |